Invesco Ltd. Reduces Stock Position in Cencora, Inc. $COR

Invesco Ltd. cut its holdings in Cencora, Inc. (NYSE:COR) by 0.8% during the third quarter, Holdings Channel reports. The institutional investor owned 4,006,113 shares of the company’s stock after selling 31,769 shares during the period. Invesco Ltd.’s holdings in Cencora were worth $1,252,030,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. IAG Wealth Partners LLC acquired a new position in shares of Cencora during the 3rd quarter worth about $30,000. Vermillion & White Wealth Management Group LLC raised its position in shares of Cencora by 69.4% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 105 shares of the company’s stock worth $31,000 after acquiring an additional 43 shares in the last quarter. Cloud Capital Management LLC purchased a new stake in Cencora during the third quarter worth approximately $31,000. Caitlin John LLC purchased a new stake in Cencora during the third quarter worth approximately $31,000. Finally, Westside Investment Management Inc. boosted its holdings in Cencora by 200.0% in the third quarter. Westside Investment Management Inc. now owns 105 shares of the company’s stock valued at $33,000 after purchasing an additional 70 shares in the last quarter. 97.52% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Cencora news, CEO Robert P. Mauch sold 5,096 shares of Cencora stock in a transaction on Tuesday, January 20th. The shares were sold at an average price of $354.73, for a total value of $1,807,704.08. Following the transaction, the chief executive officer directly owned 66,726 shares in the company, valued at approximately $23,669,713.98. The trade was a 7.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Elizabeth S. Campbell sold 3,351 shares of the company’s stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $342.10, for a total transaction of $1,146,377.10. Following the completion of the sale, the executive vice president directly owned 23,891 shares of the company’s stock, valued at $8,173,111.10. The trade was a 12.30% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 15,220 shares of company stock valued at $5,282,867. Insiders own 0.38% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have commented on COR. Evercore dropped their price target on shares of Cencora from $440.00 to $420.00 and set an “outperform” rating on the stock in a research note on Thursday, February 5th. Bank of America reduced their price objective on shares of Cencora from $380.00 to $360.00 and set a “neutral” rating for the company in a research report on Monday, January 5th. Robert W. Baird set a $415.00 target price on shares of Cencora in a report on Tuesday, January 13th. Barclays increased their target price on shares of Cencora from $400.00 to $425.00 and gave the company an “overweight” rating in a research report on Friday, February 13th. Finally, Weiss Ratings upgraded shares of Cencora from a “hold (c+)” rating to a “buy (b)” rating in a research note on Thursday, February 5th. Eleven research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $399.00.

Cencora Trading Up 0.6%

COR opened at $352.39 on Friday. The company has a quick ratio of 0.51, a current ratio of 0.92 and a debt-to-equity ratio of 3.62. Cencora, Inc. has a 52 week low of $252.49 and a 52 week high of $377.54. The business’s 50 day moving average is $355.37 and its two-hundred day moving average is $337.70. The firm has a market cap of $68.55 billion, a price-to-earnings ratio of 42.35, a price-to-earnings-growth ratio of 1.63 and a beta of 0.68.

Cencora (NYSE:COR) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $4.08 earnings per share for the quarter, beating the consensus estimate of $4.04 by $0.04. The business had revenue of $85.93 billion during the quarter, compared to the consensus estimate of $86.12 billion. Cencora had a return on equity of 176.54% and a net margin of 0.50%.The company’s revenue was up 5.5% compared to the same quarter last year. During the same period in the prior year, the company earned $3.73 earnings per share. On average, research analysts predict that Cencora, Inc. will post 15.37 EPS for the current year.

Cencora Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 2nd. Shareholders of record on Friday, February 13th were given a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend was Friday, February 13th. Cencora’s dividend payout ratio (DPR) is presently 28.85%.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.